Japan-based M3 Inc Acquires Majority Stake in Bangalore-based Neuroglia Health
22 April 2019 9:47 PM GMT
Japanese healthcare firm M3, Inc has acquired a majority share in Bengaluru-based startup Neuroglia Health, which provides web-based applications for
- Japanese healthcare firm M3, Inc has acquired a majority share in Bengaluru-based startup Neuroglia Health, which provides web-based applications for doctors and medical students in India.
- Neuroglia Health owns and operates a mobile app called 'DailyRounds' (fomerly known as Medengage), which enables case-based problem-solving for doctors.
- "With this majority acquisition, M3 India will now be able to reach out to 450,000 doctors in India on a consolidated basis, while enhancing the utility and satisfaction levels among Doctors by leveraging the strengths of both platforms.
- Established in September 2000 under the service name of So-net, with Sony Communications Network Corporation, M3 also intends to import services and technologies developed in Japan and internationally into India, such as job placement support services and AI applications, with an aim to build next-generation healthcare technologies in India.
Next Story
